Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 05:29PM CEST
| Previous close | 221.00 |
| Open | 220.00 |
| Bid | 220.20 x 0 |
| Ask | 220.60 x 0 |
| Day's range | 219.40 - 222.00 |
| 52-week range | 194.47 - 273.80 |
| Volume | |
| Avg. volume | 410,573 |
| Market cap | 68.641B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 22.01 |
| EPS (TTM) | 10.03 |
| Earnings date | 26 Oct 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 278.57 |
PR NewswireReminder: Sobi KOL investor event: Advancing the standard of care in haemophilia
Sobi invites investors to participate in a virtual KOL haemophilia event on 18 September 2023 at 15:00 CEST.
PR NewswireSobi KOL investor event: Advancing the standard of care in haemophilia
Sobi invites investors to participate in a virtual KOL haemophilia event on 18 September 2023 at 15:00 CEST.
ZacksNurix Therapeutics, Inc. (NRIX) Soars 8.3%: Is Further Upside Left in the Stock?
Nurix Therapeutics, Inc. (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2023 Yahoo. All rights reserved.
